50
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Are Saudi Arabian Patients Willing to Be Deprescribed Their Medications? An Exploratory Study

ORCID Icon &
Pages 779-786 | Received 27 Oct 2023, Accepted 05 Mar 2024, Published online: 27 Mar 2024

References

  • Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17:1–10.
  • Wastesson JW, Morin L, Tan ECK, Johnell K. An update on the clinical consequences of polypharmacy in older adults: a narrative review. Expert Opin Drug Saf. 2018;17(12):1185–1196. doi:10.1080/14740338.2018.1546841
  • Reeve E, Gnjidic D, Long J, Hilmer S. A systematic review of the emerging definition of ‘deprescribing’ with network analysis: implications for future research and clinical practice. Br J Clin Pharmacol. 2015;80(6):1254–1268. doi:10.1111/bcp.12732
  • Scott IA, Hilmer SN, Reeve E, et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med. 2015;175(5):827–834. doi:10.1001/jamainternmed.2015.0324
  • Gokula M, Holmes HM. Tools to reduce polypharmacy. Clin Geriatr Med. 2012;28(2):323–341. doi:10.1016/j.cger.2012.01.011
  • Page AT, Clifford RM, Potter K, Schwartz D, Etherton‐Beer CD. The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta‐analysis. Br J Clin Pharmacol. 2016;82(3):583–623. doi:10.1111/bcp.12975
  • Reeve E, Wiese MD, Hendrix I, Roberts MS, Shakib S. People’s attitudes, beliefs, and experiences regarding polypharmacy and willingness to deprescribe. J Am Geriatr Soc. 2013;61(9):1508–1514. doi:10.1111/jgs.12418
  • Farrell B, Mangin D. Deprescribing is an essential part of good prescribing. Am Fam Physician. 2019;99(1):7–9.
  • Stewart D, Mair A, Wilson M, et al. Guidance to manage inappropriate polypharmacy in older people: systematic review and future developments. Expert Opin Drug Saf. 2017;16(2):203–213. doi:10.1080/14740338.2017.1265503
  • AlRasheed MM, Alhawassi TM, Alanazi A, Aloudah N, Khurshid F, Alsultan M. Knowledge and willingness of physicians about deprescribing among older patients: a qualitative study. Clin Interv Aging. 2018;13:1401–1408. doi:10.2147/CIA.S165588
  • Aljawadi MH, Khoja AT, Alaboud NM, et al. Prevalence of polypharmacy and factors associated with it among Saudi older adults – results from the Saudi National Survey for Elderly Health (SNSEH). Saudi Pharm J. 2022;30(3):230–236. doi:10.1016/j.jsps.2022.01.003
  • Reeve E, Wiese MD. Benefits of deprescribing on patients’ adherence to medications. Int J Clin Pharm. 2014;36(1):26–29. doi:10.1007/s11096-013-9871-z
  • Reeve E, Low L-F, Shakib S, Hilmer SN. Development and validation of the revised patients’ attitudes towards deprescribing (rPATD) questionnaire: versions for older adults and caregivers. Drugs Aging. 2016;33(12):913–928. doi:10.1007/s40266-016-0410-1
  • Nusair MB, Arabyat R, Al-Azzam S, El-Hajji FD, Nusir AT, Al-Batineh M. Translation and psychometric properties of the Arabic version of the revised patients’ attitudes towards deprescribing questionnaire. J Pharm Health Ser Res. 2020;11(2):173–181. doi:10.1111/jphs.12340
  • Pereira A, Ó R, Veríssimo M. Predictors of older patients’ willingness to have medications deprescribed: a cross‐sectional study. Basic Clin Pharmacol Toxicol. 2023;133(6):703–717. doi:10.1111/bcpt.13874
  • Oktora MP, Yuniar CT, Amalia L, Abdulah R, Hak E, Denig P. Attitudes towards deprescribing and patient-related factors associated with willingness to stop medication among older patients with type 2 diabetes (T2D) in Indonesia: a cross-sectional survey study. BMC Geriat. 2023;23(1):1–11. doi:10.1186/s12877-022-03718-9
  • IBM Corp. IBM SPSS statistics for windows. Volume version 28.0. IBM Corp, Armonk,NY; Released 2021.
  • Oktora MP, Edwina AE, Denig P. Differences in older patients’ attitudes toward deprescribing at contextual and individual level. Front Public Health. 2022;10:795043. doi:10.3389/fpubh.2022.795043
  • Burghle A, Lundby C, Ryg J, et al. Attitudes towards deprescribing among older adults with limited life expectancy and their relatives: a systematic review. Drugs Aging. 2020;37:503–520. doi:10.1007/s40266-020-00774-x
  • Forest E, Ireland M, Yakandawala U, et al. Patient values and preferences on polypharmacy and deprescribing: a scoping review. Int J Clin Pharm. 2021;43(6):1461–1499. doi:10.1007/s11096-021-01328-w
  • Alshamrani M, Almalki A, Qureshi M, Yusuf O, Ismail S. Polypharmacy and medication-related problems in hemodialysis patients: a call for deprescribing. Pharmacy. 2018;6(3):76. doi:10.3390/pharmacy6030076
  • Reeve E, To J, Hendrix I, Shakib S, Roberts MS, Wiese MD. Patient barriers to and enablers of deprescribing: a systematic review. Drugs Aging. 2013;30(10):793–807. doi:10.1007/s40266-013-0106-8
  • Oktora M, Kerr K, Hak E, Denig P. Rates, determinants and success of implementing deprescribing in people with type 2 diabetes: a scoping review. Diabetic Med. 2021;38(2):e14408. doi:10.1111/dme.14408
  • Lukacena KM, Keck JW, Freeman PR, Harrington NG, Huffmyer MJ, Moga DC. Patients’ attitudes toward deprescribing and their experiences communicating with clinicians and pharmacists. Ther Adv Drug Saf. 2022;13:20420986221116465. doi:10.1177/20420986221116465
  • Gadisa DA, Gebremariam ET, Yimer G, Deresa Urgesa E. Attitudes of older adult patients and caregivers towards deprescribing of medications in Ethiopia. Clin Interv Aging. 2023;18:1129–1143. doi:10.2147/CIA.S400698